Next Article in Journal
Concurrent Heat Waves and Extreme Ozone (O3) Episodes: Combined Atmospheric Patterns and Impact on Human Health
Next Article in Special Issue
Public Health Implications of Cannabis Legalization: An Exploration of Adolescent Use and Evidence-Based Interventions
Previous Article in Journal
Trends in the Epidemiology and Outcomes of Pneumocystis Pneumonia among Human Immunodeficiency Virus (HIV) Hospitalizations
Previous Article in Special Issue
Disparity between Perceptual Fall Risk and Physiological Fall Risk in Older Cannabis Users: A Pilot Study
Systematic Review

The Construct of Medical and Non-Medical Marijuana—Critical Review

1
Department of Public Health, Medical University of Warsaw, 02-091 Warszawa, Poland
2
Third Department of Psychiatry, Institute of Psychiatry and Neurology, 02-957 Warszawa, Poland
3
Masovian Specialized Health Center, 05-802 Pruscow, Poland
4
Department of Psychology, SWPS University of Social Sciences and Humanities, 03-815 Warszawa, Poland
*
Author to whom correspondence should be addressed.
Academic Editors: Elisardo Becoña Iglesias, Lucy J. Troup, Thorsten Rudroff and Simon Erridge
Int. J. Environ. Res. Public Health 2022, 19(5), 2769; https://doi.org/10.3390/ijerph19052769
Received: 26 December 2021 / Revised: 19 February 2022 / Accepted: 23 February 2022 / Published: 27 February 2022
(This article belongs to the Special Issue Health Effects of Cannabis Use)
The rising popularity of medical marijuana and its potential therapeutic uses has resulted in passionate discussions that have mainly focused on its possible benefits and applications. Although the concept itself seems promising, the multitude of presented information has noticeable ramifications—terminological chaos being one. This work aimed to synthesize and critically analyze scientific evidence on the therapeutic uses of cannabinoids in the field of psychiatry. Emphasis was placed on the anxiolytic effects of cannabis constituents and their effects on post-traumatic stress disorder, anxiety disorders, schizophrenia spectrum, and other psychotic disorders. The review was carried out from an addictological perspective. A database search of interchangeably combined keywords resulted in the identification of subject-related records. The data were then analyzed in terms of relevance, contents, methodologies, and cited papers. The results were clear in supporting one common conclusion: while most findings provide support for beneficial applications of medical marijuana in psychiatry, no certain conclusions can be drawn until larger-scaled, more methodologically rigorous, and (preferably) controlled randomized trials verify these discoveries. View Full-Text
Keywords: anxiety; anxiolytic; cannabinoids; CBD; medical marijuana; psychiatry; psychosis; PTSD; THC; treatment anxiety; anxiolytic; cannabinoids; CBD; medical marijuana; psychiatry; psychosis; PTSD; THC; treatment
MDPI and ACS Style

Silczuk, A.; Smułek, D.; Kołodziej, M.; Gujska, J. The Construct of Medical and Non-Medical Marijuana—Critical Review. Int. J. Environ. Res. Public Health 2022, 19, 2769. https://doi.org/10.3390/ijerph19052769

AMA Style

Silczuk A, Smułek D, Kołodziej M, Gujska J. The Construct of Medical and Non-Medical Marijuana—Critical Review. International Journal of Environmental Research and Public Health. 2022; 19(5):2769. https://doi.org/10.3390/ijerph19052769

Chicago/Turabian Style

Silczuk, Andrzej, Daria Smułek, Marcin Kołodziej, and Julia Gujska. 2022. "The Construct of Medical and Non-Medical Marijuana—Critical Review" International Journal of Environmental Research and Public Health 19, no. 5: 2769. https://doi.org/10.3390/ijerph19052769

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop